You Are Here: Home » Articles posted by Lloyd Benson

Tips for Using Multimedia News Releases to Power Improved Press Release Results and Impactful Engagement

Ask any public relations professional if they’d like to increase engagement with their media audience and 100 times out of one hundred the answer will be a resounding yes!!  All PR pros seek to find new and creative ways to broaden the scope, breadth and depth of the way the media covers their “news.” One relatively new way to ensure your “stories” not only get better play ...

Read more

Twenty Years of PR – Is Past Prologue?

This post will kick off a series of twenty posts in symbolic commemoration of the twenty year anniversary of Schwartz Communications and our twenty years of work representing some of the most exciting biopharma and medtech companies and developments to from the past two decades.  Going forward you’ll be hearing from more of us in the healthcare group at Schwartz as well as others whom we’ve ...

Read more

CDRH’s Office of Compliance Increases Size of Device Advertising and Promotion Policy Group

Just a week ago, FDA Regulatory Counsel Deborah Wolf announced that CDRH’s Office of Compliance had tripled the size of its Advertising and Promotion Policy Group.Now truthfully, the staff increase from one to three members pales compared to FDA’s drug center, which employs 60 staffers in a similar role. But device companies should be able to easily read the tea leaves on this move, which should ...

Read more

Inspiration and Perspiration in PR

Yesterday I met with an interesting company that was interviewing healthcare public relations agencies. They had developed a detailed set of criteria for the PR agency that they were going to select. This is not uncommon, in fact, it is de rigeur.  In this case, management kept coming back to their desire to hire an agency that “thinks out of the box,” and is “highly creative.” ...

Read more

New York Times Report on Radiation: Balanced or too Sensational?

The January 24th edition of the Sunday New York Times ran a Page One Investigative report on the perils and dire consequences on the use of radiation in medical diagnostics and cancer therapies. The lengthy report, put together by an investigative team of six people, left the reader chilled and saddened for the families of the two patients whose experiences formed the substance of the vast majority of the T ...

Read more

The Politicians Should Hire a Healthcare PR Agency

Every day now, ubiquitous across all types of media, both Democrats and Republicans are in full-throated discourse (a polite term) debating the future of America’s health care system. The discussion is decidedly unpolite, loud, passionate and to say the least, confusing. The Democrats, ardent supporters of major overhauls to our current healthcare system, have (to me anyway) yet to paint a cogent and ...

Read more

Social Media and the Healthcare Company: Opportunities and Challenges

Perhaps no single item in recent memory has generated as much curiosity and interest from healthcare PR Pros and marketers than has the growing phenomenon broadly titled "Social Media".  Social Media can be broadly defined as a whole group of new communications channels that enable a more direct and conversational dialogue between medical device, pharmaceutical and biopharma companies and the ...

Read more

Politics, Stem Cells and the FDA

 One of the more interesting recent medical stories to hit the mainstream media was the news that for the first time, the FDA has cleared the use of embryonic stem cells in human clinical trials. This particular trial will use a stem cell line developed by Geron, Inc. of Menlo Park, CA and will be implanted in people who have suffered acute spinal cord injury. As somebody who has actually seen the Gero ...

Read more